Reduced IV Fluids to Improve Clearance of HDMTX in Children w/Lymphoma or Acute Lymphoblastic Leukemia
Clinical trial NCT03964259 · COMPLETED
Trial details
- NCT number
- NCT03964259
- Sponsor
- Virginia Commonwealth University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-02
- Primary completion
- 2022-12-07
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.